Divi's Laboratories Share Price

  • 3,765.15100.16 (2.73%)
  • Volume: 2,96,674
  • Closed
  • Last Updated On: 29 Sep, 2023, 03:57 PM IST

Divis Labs share price insights

  • Sales de-grew by 10.6%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 12.55% towards employee cost in the year ending 31 Mar, 2023. (Source: Consolidated Financials)

  • Divi's Laboratories Ltd. share price moved up by 2.73% from its previous close of Rs 3,665.00. Divi's Laboratories Ltd. stock last traded price is 3,765.15

    Share PriceValue
    Previous Day3,665.003,663.85

InsightsDivis Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    EPS - TTM
    (₹ Cr.)
    Sectoral MCap Rank
    PB Ratio
    Div Yield
    Face Value


    1 Month1.54
    3 Months0.83
    6 Months0.77
    1 Year1.01
    3 Years1.06

    52W H/L
    3,934.70 / 2,730.00

    Divis Labs Share Price Returns

    1 Day2.73%
    1 Week1.62%
    1 Month2.95%
    3 Months4.54%
    1 Year1.94%
    3 Years22.97%
    5 Years187.22%

    ET Stock ScreenersTop Score Companies

    Check whether Divis Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Divis Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance

    Divis Labs Share Recommendations

    Recent Recos



    Mean Recos by 19 Analysts


    That's all for Divis Labs recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy3333
    Strong Sell3333
    # Analysts19192121

    Divis Labs Share Price Forecast

    • PRICE



    • Get multiple analysts’ prediction on Divis Labs

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
    • Get multiple analysts’ prediction on Divis Labs

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
    • Get multiple analysts’ prediction on Divis Labs

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings

    Peer Comparison

    • Divis Labs Stock Performance

    • Ratio Performance

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Divis Labs67.667.8314.2817.7612.6213.1230.5023.4768.698.460.000.00
      Dr. Reddys19.704.0019.3525.9513.9612.2224.9418.12271.472.380.050.19
      Mankind Pharma57.369.4317.2421.6913.1913.9619.4614.8232.002.320.020.09
      Torrent Pharma51.8210.5320.0922.798.296.1722.6612.9436.790.980.852.24
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Cadila Healthcare
      • Aurobindo Pharma
      • Lupin
      • Alkem Labs
      • Biocon

      Choose from Stocks

      Peers InsightsDivis Labs

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Divis Labs Shareholding Pattern

        • QOQ Change

        • Total Shareholdings

        • Loading...
          Showing Divis Labs Shareholding as on 30 Jun 2023
          Category30 Jun 202331 Mar 202331 Dec 202230 Sep 2022
          Mutual Funds13.2013.1512.6813.62
        • Showing Shareholding as on 30 Jun 2023
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters13,78,56,60051.93 %-0.01
          Pledge00.00 %0.00
          FII3,90,19,62014.69 %0.02
          DII5,58,02,48921.03 %0.14
          MF3,50,37,87113.20 %0.05
          Others3,27,89,87112.35 %-0.15

        MF Ownership

        MF Ownership as on 31 August 2023

        Divis Labs F&O Quote

        • Futures

        • Options

          • Expiry


          3,784.0093.10 (2.52%)

          Open Interest

          23,05,800-94,200 (-4.09%)

          OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)

          Open Interest as of 29 Sep 2023

        Corporate Actions

        • Divis Labs Board Meeting/AGM

        • Divis Labs Dividends

        • Others
        • Meeting DateAnnounced onPurposeDetails
          Aug 14, 2023Aug 07, 2023Board MeetingQuarterly Results
          May 20, 2023May 12, 2023Board MeetingAudited Results & Final Dividend
          Feb 03, 2023Jan 23, 2023Board MeetingQuarterly Results
          Nov 07, 2022Oct 28, 2022Board MeetingQuarterly Results
          Aug 22, 2022Jul 04, 2022AGM-
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final1500%30.0Aug 11, 2023May 22, 2023
          Final1500%30.0Aug 11, 2022May 23, 2022
          Final1000%20.0Aug 17, 2021May 31, 2021
          Interim800%16.0Feb 25, 2020Feb 12, 2020
          Final800%16.0Aug 14, 2019May 27, 2019
        • All TypesEx-DateRecord DateAnnounced onDetails
          BonusSep 23, 2015Sep 26, 2015Aug 08, 2015Bonus Ratio: 1 share(s) for every 1 shares held
          BonusJul 30, 2009Aug 01, 2009Jun 06, 2009Bonus Ratio: 1 share(s) for every 1 shares held
          SplitsAug 03, 2007-May 23, 2007Split: Old FV10.0| New FV:2.0

        About Divis Labs

        Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99,952.90 Crore) operating in Pharmaceuticals sector. Divi's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Contract Fees for the year ending 31-Mar-2022. Show More

        • Executives

        • Auditors

        • RB

          Ramesh B V Nimmagadda

          Non Exe.Chairman&Ind.Director

          Murali K Divi

          Managing Director

          Kiran S Divi

          WholeTime Director & CEO

          Madhusudana Rao Divi

          Whole Time Director

          Nilima Prasad Divi

          Whole Time Director

          N V Ramana

          Executive Director
          Show More
        • Price Waterhouse Chartered Accountants LLP

        Key Indices Listed on

        Nifty 50, Nifty 100, Nifty 200, + 30 more


        Divi Towers,1-72/23(P)/DIVIS/303,Cyber Hills, Gachibowli,Hyderabad, Telangana - 500032


        Divis Labs

        FAQs about Divis Labs share

        • 1. What's Divis Labs share price today and what are Divis Labs share returns ?
          Divis Labs share price was Rs 3,765.15 as on 29 Sep, 2023, 03:57 PM IST. Divis Labs share price was up by 2.73% based on previous share price of Rs 3,665. Divis Labs share price trend:
          • Last 1 Month: Divis Labs share price moved up by 2.95%
          • Last 3 Months: Divis Labs share price moved up by 4.54%
          • Last 12 Months: Divis Labs share price moved up 1.94%
          • Last 3 Years: Divis Labs Share price moved up by 22.97%
        • 2. What is the market cap of Divis Labs?
          Divis Labs share has a market capitalization of Rs 99,952.90 Cr. Within Pharmaceuticals sector, it's market cap rank is 2.
        • 3. Should I buy, sell or hold Divis Labs?
          As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 19 analysts for Divis Labs stock is to Hold. Recommendation breakup is as follows
          • 3 analysts are recommending Strong Buy
          • 1 analyst is recommending to Buy
          • 3 analysts are recommending to Hold
          • 9 analysts are recommending to Sell
          • 3 analysts are recommending Strong Sell
        • 4. Who are peers to compare Divis Labs share price?
          Within Pharmaceuticals sector Divis Labs, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Biocon Ltd. and Syngene International Ltd. are usually compared together by investors for analysis.
        • 5. Who's the owner of Divis Labs?
          Following are the key changes to Divis Labs shareholding:
          • Promoter holding have gone down from 51.94 (30 Sep 2022) to 51.93 (30 Jun 2023)
          • Domestic Institutional Investors holding has gone up from 20.64 (30 Sep 2022) to 21.03 (30 Jun 2023)
          • Foreign Institutional Investors holding have gone down from 15.4 (30 Sep 2022) to 14.69 (30 Jun 2023)
          • Other investor holding has gone up from 12.02 (30 Sep 2022) to 12.35 (30 Jun 2023)
        • 6. What is 52 week high/low of Divis Labs share price?
          Divis Labs share price saw a 52 week high of Rs 3,934.70 and 52 week low of Rs 2,730.00.
        • 7. How can I quickly analyze Divis Labs stock?
          Divis Labs share can be quickly analyzed on following metrics:
          • Stock's PE is 67.66
          • Price to Book Ratio of 7.93
          • Dividend Yield of 0.80
          • EPS (trailing 12 month) of Divis Labs share is 55.65

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times